Recently, respiratory disease testing company Spirometrix announced the completion of a $17.4 million Series C financing, led by Shanghai Fosun Pharma, and South Valley Angels, Iconical Fund Advisors, Ohio Innovation Foundation and Carmen Innovation LLC.

In recent years, exhaled nitric oxide (FeNO) has become a new important biomarker for the detection of asthma diseases. This led to the establishment of Spirometrix in 2011. Founders Dr. Solomon Ssenyange and Ryan Leard are dedicated to the development and commercialization of innovative detection technologies for asthma diagnosis and disease management. The technology they rely on for sensors is based on research by Professor Prabir Dutta of Ohio State University in his innovation lab.

Spirometiix CEO J. Dean Zikria said the company's first product, the Fenom PRO Portable Asthma Detector, is an unprecedented product in the asthma industry that includes multiple sensing technologies and a digital respiratory ecosystem to assist in clinical decision making. Spirometrix's digital respiratory ecosystem will also include data from other instruments or environments, such as local pollen levels, local pollution indices and air quality, which will introduce pattern recognition and pattern management for asthma for the first time. Now, the Spirometiix three rounds of financing totaled $29 million.

"FeNO monitoring potentially optimizes asthma treatment in asthma patient management, improves drug compliance, and reduces the need for emergency and hospitalization for asthma patients," added Dr. James Wolfe, professor of clinical medicine at Stanford University and corporate science consultant. The Thoracic Society and the European Respiratory Society have issued a gold standard recommending the FeNO test for long-term monitoring, management, and evaluation of asthma."

“We are very happy with the investors in the last round of the investment.” Zikria said: “And this investment by China Fosun also shows that our products not only have markets in Europe and North America, but also have prospects in China. China has 3000. 10,000 asthma patients, and this number is still growing." Chen Qiyu, chairman of Fosun Pharma, said that with the increasing concern of Chinese society on respiratory health and disease treatment, Fosun Pharma hopes to use this investment to develop the field of respiratory testing and treatment.

Bathroom Anti Slip Tape

Bathroom Anti Slip Tape

Bathroom anti slip tape from Jerrytape is based on soft PEVA or PU material, which is environmentally friendly and skin friendly, people can walk on it without shoes. It`s coated with upgraded acrylic adhesive, has excellent waterproof ability and good adhesion. It can be used for many wet and smooth areas, even can be used under water, such as bathroom, bathtub, swimming pool, stairs, kitchens, gymnasiums, ship, etc. And it leaves no residue when removal, easy to clean. Compared to general anti slip tape, it is PVC free and sands free.

Product specifications:

Product name: Bathroom anti slip tape / PEVA anti slip tape

Colors: Clear, black, white, grey, also offer printing.

Sizes: 25mm / 50mm / 75mm / 100mm /150mm x 3m / 5m / 18m/ 25m. Also can customize almost any size according to your demand. Also can offer sheets, such as 20 x 380mm strips, 4" x 24", 4" x 32", 6" x 30", 6" x 32", 8" x 40" treads, which are very hot sell on Amazon. Also can be special shapes, such as round sheets, snow shape, S shape, etc.

Package: Shrink wrapped or OEM package, such as Shrink + round card, shrink + sleeve card, shrink + color box, etc.

Bathroom anti slip tape, PEVA anti slip tape, non slip treads, anti slip treads, shower anti slip tape

Kunshan Jieyudeng Intelligent Technology Co., Ltd. , https://www.jerrytapes.com